Use of synthetic DNA spike-in controls (sequins) for human genome sequencing.


Journal

Nature protocols
ISSN: 1750-2799
Titre abrégé: Nat Protoc
Pays: England
ID NLM: 101284307

Informations de publication

Date de publication:
07 2019
Historique:
received: 30 06 2017
accepted: 03 04 2019
pubmed: 21 6 2019
medline: 26 11 2019
entrez: 21 6 2019
Statut: ppublish

Résumé

Next-generation sequencing (NGS) has been widely adopted to identify genetic variants and investigate their association with disease. However, the analysis of sequencing data remains challenging because of the complexity of human genetic variation and confounding errors introduced during library preparation, sequencing and analysis. We have developed a set of synthetic DNA spike-ins-termed 'sequins' (sequencing spike-ins)-that are directly added to DNA samples before library preparation. Sequins can be used to measure technical biases and to act as internal quantitative and qualitative controls throughout the sequencing workflow. This step-by-step protocol explains the use of sequins for both whole-genome and targeted sequencing of the human genome. This includes instructions regarding the dilution and addition of sequins to human DNA samples, followed by the bioinformatic steps required to separate sequin- and sample-derived sequencing reads and to evaluate the diagnostic performance of the assay. These practical guidelines are accompanied by a broader discussion of the conceptual and statistical principles that underpin the design of sequin standards. This protocol is suitable for users with standard laboratory and bioinformatic experience. The laboratory steps require ~1-4 d and the bioinformatic steps (which can be performed with the provided example data files) take an additional day.

Identifiants

pubmed: 31217595
doi: 10.1038/s41596-019-0175-1
pii: 10.1038/s41596-019-0175-1
doi:

Substances chimiques

DNA 9007-49-2
BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2119-2151

Auteurs

James Blackburn (J)

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia.

Ted Wong (T)

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.

Bindu Swapna Madala (BS)

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.

Chris Barker (C)

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.

Simon A Hardwick (SA)

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia.

Andre L M Reis (ALM)

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia.

Ira W Deveson (IW)

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia. i.deveson@garvan.org.au.
St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia. i.deveson@garvan.org.au.

Tim R Mercer (TR)

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia. t.mercer@garvan.org.au.
St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia. t.mercer@garvan.org.au.
Altius Institute for Biomedical Sciences, Seattle, WA, USA. t.mercer@garvan.org.au.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH